ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets tough leukemias
Disease control CompletedThis early-phase study tested a combination of two drugs—veliparib and temozolomide—in 66 adults with acute leukemias that had come back or not responded to standard treatment. The goal was to find the safest dose and see how well the combination worked. Veliparib blocks a repair…
Matched conditions: ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a combination of two drugs, ibrutinib and blinatumomab, in 19 adults whose B-cell acute lymphoblastic leukemia (B-ALL) had returned or stopped responding to treatment. The goal was to see if the combination could improve remission rates. Participants received bo…
Matched conditions: ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 14, 2026 12:03 UTC